Top News

• Draft Guidance Clarifies Orange Book Patent Submission Forms
• Welireg-Keytruda Combo OKd as Adjuvant Kidney Cancer Therapy
• Amgen Outlines Basis for Hearing in Tavneos Withdrawal Effort
• Jazz Trial Misses Survival Endpoint for Zepzelca in Lung Cancer
• AstraZeneca's Truqap for Prostate Cancer Approved
• Doctor, Staff Charged with Falsifying Trial Data
• 17 Senate Democrats Hit HHS on FDA, Other Changes
• Zasocitinib Beats Sotyktu in Head-to-Head Study: Takeda